|
Correlation between serum GDF-15, serum PⅠCP and PⅢNP in
patients with chronic heart failure
ZENG Chao, YU Pan-pan, LI Cai-hong, CHEN Wan-li, ZHU Zhen-yu, QI Xin
2019, 47 (1):
42-46.
doi: 10.11958/20181360
Objective To detect the changes of serum growth differentiation factor 15 (GDF-15) and type Ⅰ procollagen carboxy
terminal peptide (PⅠCP) and type Ⅲ procollagen amino terminal peptide (PⅢNP) in patients with heart failure, and to analyze the
correlation between GDF-15, PⅠCP and PⅢNP, and to explore the guiding role of GDF-15 in ventricular remodeling in patients with
heart failure. Methods A total of 219 patients with heart failure were enrolled. Patients were divided into heart function Ⅰ grade (n=
58), Ⅱ grade (n=39), Ⅲ grade (n=47), and Ⅳ grade (n=75) groups in accordance with New York Heart Association (NYHA). According
to left ventricular ejection fraction (LVEF), the heart failure patients were divided into heart failure with reduced LVEF group (LVEF<
0.45, n=69) and heart failure with preserved LVEF group (LVEF≥0.45, n=150). And 32 healthy subjects were chosen as the control
group. Serum levels of GDF-15, PⅠCP, and PⅢNP were measured by ELISA. Left ventricular end-diastolic diameter (LVEDD), left
atrial (LA), interventricular septal thickness (IVST), left ventricular posterior wall thickness (LVPWT), and left ventricular ejection
fraction (LVEF) were measured by echocardiography. The left ventricular mass index (LVMI) was calculated. And also the correlation
between serum GDF-15 and PⅠCP, PⅢNP, NT-proBNP, LVEDD, LA, LVMI and LVEF were analyzed in patients with heart failure.
Results Serum levels of GDF-15, PⅠCP, PⅢNP and NT-proBNP were significantly elevated in patients with heart failure (P<
0.05), and increased with the increasing NYHA classification. The serum levels of LA, LVEDD, LVMI, NT-proBNP, GDF-15, PⅠCP
and PⅢNP were increased in turn in control group, HFpEF group and HFrEF group (P<0.05). Serum GDF-15 levels were positively
correlated with PⅠCP, PⅢNP, NT-proBNP, LA, LVEDD, and LVMI in patients with heart failure (rs=0.549, 0.533, 0.539, 0.393,
0.403, 0.485, P<0.01), and negatively correlated with LVEF (rs=-0.568, P<0.01). Conclusion Serum GDF-15 is associated with
the severity of heart failure and may reflect ventricular remodeling in patients with heart failure.
Related Articles |
Metrics
|